Phase I Clinical Trial of Fibronectin CH296-Stimulated T Cell Therapy in Patients with Advanced Cancer-Reference-Cited by-同舟云学术

Phase I Clinical Trial of Fibronectin CH296-Stimulated T Cell Therapy in Patients with Advanced Cancer

Published:2014-01-31 Issue:1 Volume:9 Page:e83786
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ishikawa Takeshi,Kokura Satoshi,Enoki Tatsuji,Sakamoto Naoyuki,Okayama Tetsuya,Ideno Mitsuko,Mineno Junichi,Uno Kazuko,Yoshida Naohisa,Kamada Kazuhiro,Katada Kazuhiro,Uchiyama Kazuhiko,Handa Osamu,Takagi Tomohisa,Konishi Hideyuki,Yagi Nobuaki,Naito Yuji,Itoh Yoshito,Yoshikawa Toshikazu

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference31 articles.

1. Nonmyeloablative allogeneic immunotherapy for solid tumors;RW Childs;Annu Rev Med,2004

2. Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells;L Gattinoni;J Clin Invest,2005

3. Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy;PF Robbins;J Immunol,2004

4. Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy;J Zhou;J Immunol,2005

5. Survival, persistence, and progressive differentiation of adoptively transferred tumor-reactive T cells associated with tumor regression;J Huang;J Immunother,2005

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New insights into the mechanisms of the extracellular matrix and its therapeutic potential in anaplastic thyroid carcinoma;Scientific Reports;2024-09-09

2. Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy;Cell Death & Disease;2024-05-01

3. The role of fibronectin in mediating cell migration;American Journal of Physiology-Cell Physiology;2024-04-01

4. Tumor microenvironment signaling and therapeutics in cancer progression;Cancer Communications;2023-04-02

5. Recent Progress on the Role of Fibronectin in Tumor Stromal Immunity and Immunotherapy;Current Topics in Medicinal Chemistry;2022-11